
Titilayo Moloye
Examiner (ID: 2273, Phone: (571)270-1094 , Office: P/1632 )
| Most Active Art Unit | 1632 |
| Art Unit(s) | 1632 |
| Total Applications | 610 |
| Issued Applications | 327 |
| Pending Applications | 113 |
| Abandoned Applications | 206 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19826453
[patent_doc_number] => 12247219
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-03-11
[patent_title] => Method for inducing differentiation of corneal epithelial cells from pluripotent stem cells
[patent_app_type] => utility
[patent_app_number] => 17/348174
[patent_app_country] => US
[patent_app_date] => 2021-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 25
[patent_no_of_words] => 9247
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 279
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17348174
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/348174 | Method for inducing differentiation of corneal epithelial cells from pluripotent stem cells | Jun 14, 2021 | Issued |
Array
(
[id] => 17126483
[patent_doc_number] => 20210301251
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-30
[patent_title] => METHODS FOR GENERATING AND USING ORGANOIDS AND TISSUE THEREIN
[patent_app_type] => utility
[patent_app_number] => 17/344064
[patent_app_country] => US
[patent_app_date] => 2021-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11225
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17344064
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/344064 | Methods for generating and using organoids and tissue therein | Jun 9, 2021 | Issued |
Array
(
[id] => 18510060
[patent_doc_number] => 20230226158
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-20
[patent_title] => COMPOSITIONS AND METHODS FOR TREATING AND/OR PREVENTING COAGULOPATHY AND/OR SEPSIS IN PATIENTS SUFFERING FROM BACTERIAL AND/OR VIRAL INFECTIONS
[patent_app_type] => utility
[patent_app_number] => 18/000957
[patent_app_country] => US
[patent_app_date] => 2021-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20103
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18000957
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/000957 | COMPOSITIONS AND METHODS FOR TREATING AND/OR PREVENTING COAGULOPATHY AND/OR SEPSIS IN PATIENTS SUFFERING FROM BACTERIAL AND/OR VIRAL INFECTIONS | Jun 7, 2021 | Pending |
Array
(
[id] => 17113704
[patent_doc_number] => 20210294301
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-23
[patent_title] => METHOD AND APPARATUS FOR A TISSUE ENGINEERING SYSTEM UTILIZING STACKED LAYERS
[patent_app_type] => utility
[patent_app_number] => 17/340434
[patent_app_country] => US
[patent_app_date] => 2021-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13249
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 274
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17340434
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/340434 | METHOD AND APPARATUS FOR A TISSUE ENGINEERING SYSTEM UTILIZING STACKED LAYERS | Jun 6, 2021 | Pending |
Array
(
[id] => 19449215
[patent_doc_number] => 20240309345
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-19
[patent_title] => COMPOSITIONS AND METHODS FOR GENE EDITING
[patent_app_type] => utility
[patent_app_number] => 17/999756
[patent_app_country] => US
[patent_app_date] => 2021-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 57012
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17999756
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/999756 | COMPOSITIONS AND METHODS FOR GENE EDITING | May 31, 2021 | Pending |
Array
(
[id] => 19449215
[patent_doc_number] => 20240309345
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-19
[patent_title] => COMPOSITIONS AND METHODS FOR GENE EDITING
[patent_app_type] => utility
[patent_app_number] => 17/999756
[patent_app_country] => US
[patent_app_date] => 2021-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 57012
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17999756
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/999756 | COMPOSITIONS AND METHODS FOR GENE EDITING | May 31, 2021 | Pending |
Array
(
[id] => 17604268
[patent_doc_number] => 11332741
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2022-05-17
[patent_title] => Compositions and methods for treating leber's hereditary optic neuropathy
[patent_app_type] => utility
[patent_app_number] => 17/320388
[patent_app_country] => US
[patent_app_date] => 2021-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 24971
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 128
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17320388
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/320388 | Compositions and methods for treating leber's hereditary optic neuropathy | May 13, 2021 | Issued |
Array
(
[id] => 18995995
[patent_doc_number] => 11912823
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-02-27
[patent_title] => Methods of preparing a poloxamer for use in cell culture medium
[patent_app_type] => utility
[patent_app_number] => 17/319886
[patent_app_country] => US
[patent_app_date] => 2021-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 22570
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 220
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17319886
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/319886 | Methods of preparing a poloxamer for use in cell culture medium | May 12, 2021 | Issued |
Array
(
[id] => 20316135
[patent_doc_number] => 12454679
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-10-28
[patent_title] => Non-decellularized plant leaf cultures for meat
[patent_app_type] => utility
[patent_app_number] => 17/317037
[patent_app_country] => US
[patent_app_date] => 2021-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 42
[patent_no_of_words] => 3478
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 347
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17317037
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/317037 | Non-decellularized plant leaf cultures for meat | May 10, 2021 | Issued |
Array
(
[id] => 20316135
[patent_doc_number] => 12454679
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-10-28
[patent_title] => Non-decellularized plant leaf cultures for meat
[patent_app_type] => utility
[patent_app_number] => 17/317037
[patent_app_country] => US
[patent_app_date] => 2021-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 42
[patent_no_of_words] => 3478
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 347
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17317037
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/317037 | Non-decellularized plant leaf cultures for meat | May 10, 2021 | Issued |
Array
(
[id] => 17960315
[patent_doc_number] => 20220340895
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-27
[patent_title] => COMPOSITIONS AND METHODS FOR TREATING LEBER'S HEREDITARY OPTIC NEUROPATHY
[patent_app_type] => utility
[patent_app_number] => 17/317295
[patent_app_country] => US
[patent_app_date] => 2021-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24683
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17317295
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/317295 | COMPOSITIONS AND METHODS FOR TREATING LEBER'S HEREDITARY OPTIC NEUROPATHY | May 10, 2021 | Abandoned |
Array
(
[id] => 17355410
[patent_doc_number] => 20220016206
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-20
[patent_title] => ISOFORM NELL-1 PEPTIDE
[patent_app_type] => utility
[patent_app_number] => 17/315593
[patent_app_country] => US
[patent_app_date] => 2021-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8469
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17315593
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/315593 | Isoform Nell-1 peptide | May 9, 2021 | Issued |
Array
(
[id] => 18964417
[patent_doc_number] => 11898169
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-02-13
[patent_title] => Synergistic genome-nonintegrating reprogramming by microRNAs and transcription factors
[patent_app_type] => utility
[patent_app_number] => 17/239059
[patent_app_country] => US
[patent_app_date] => 2021-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 18
[patent_no_of_words] => 11515
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 117
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17239059
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/239059 | Synergistic genome-nonintegrating reprogramming by microRNAs and transcription factors | Apr 22, 2021 | Issued |
Array
(
[id] => 16990225
[patent_doc_number] => 20210228645
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-29
[patent_title] => METHODS FOR PRODUCING RETINAL TISSUE AND RETINA-RELATED CELL
[patent_app_type] => utility
[patent_app_number] => 17/227497
[patent_app_country] => US
[patent_app_date] => 2021-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15283
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17227497
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/227497 | METHODS FOR PRODUCING RETINAL TISSUE AND RETINA-RELATED CELL | Apr 11, 2021 | Pending |
Array
(
[id] => 16990225
[patent_doc_number] => 20210228645
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-29
[patent_title] => METHODS FOR PRODUCING RETINAL TISSUE AND RETINA-RELATED CELL
[patent_app_type] => utility
[patent_app_number] => 17/227497
[patent_app_country] => US
[patent_app_date] => 2021-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15283
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17227497
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/227497 | METHODS FOR PRODUCING RETINAL TISSUE AND RETINA-RELATED CELL | Apr 11, 2021 | Pending |
Array
(
[id] => 16961569
[patent_doc_number] => 20210213068
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-15
[patent_title] => PLURIPOTENT STEM CELL FOR TREATMENT OF CEREBRAL INFARCTION
[patent_app_type] => utility
[patent_app_number] => 17/219430
[patent_app_country] => US
[patent_app_date] => 2021-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6098
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17219430
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/219430 | PLURIPOTENT STEM CELL FOR TREATMENT OF CEREBRAL INFARCTION | Mar 30, 2021 | Pending |
Array
(
[id] => 17814310
[patent_doc_number] => 11419898
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-08-23
[patent_title] => Combinatorial cancer immunotherapy
[patent_app_type] => utility
[patent_app_number] => 17/219569
[patent_app_country] => US
[patent_app_date] => 2021-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 120
[patent_figures_cnt] => 122
[patent_no_of_words] => 62423
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 329
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17219569
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/219569 | Combinatorial cancer immunotherapy | Mar 30, 2021 | Issued |
Array
(
[id] => 16913995
[patent_doc_number] => 20210187087
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-24
[patent_title] => TARGETING DNA VACCINES TO B CELLS AS PRIMARY ANTIGEN PRESENTING CELLS
[patent_app_type] => utility
[patent_app_number] => 17/191378
[patent_app_country] => US
[patent_app_date] => 2021-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10173
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 208
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17191378
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/191378 | TARGETING DNA VACCINES TO B CELLS AS PRIMARY ANTIGEN PRESENTING CELLS | Mar 2, 2021 | Abandoned |
Array
(
[id] => 16913975
[patent_doc_number] => 20210187067
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-24
[patent_title] => TREATMENT OF DISEASES INVOLVING DEFICIENCY OF ENPP1 OR ENPP3
[patent_app_type] => utility
[patent_app_number] => 17/178127
[patent_app_country] => US
[patent_app_date] => 2021-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 42781
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17178127
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/178127 | TREATMENT OF DISEASES INVOLVING DEFICIENCY OF ENPP1 OR ENPP3 | Feb 16, 2021 | Abandoned |
Array
(
[id] => 16822763
[patent_doc_number] => 20210138056
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-13
[patent_title] => NEOEPITOPE VACCINE COMPOSITIONS AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/148324
[patent_app_country] => US
[patent_app_date] => 2021-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 51532
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17148324
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/148324 | NEOEPITOPE VACCINE COMPOSITIONS AND METHODS OF USE THEREOF | Jan 12, 2021 | Abandoned |